Observational studyEuropean journal of medical research2022

PD-1 and LAG-3-positive T cells are associated with clinical outcomes of relapsed/refractory multiple myeloma patients.

Ming Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.